• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Clinical Data

image-icon
Clinical trial failure flop
Special Reports

2021's top 10 clinical trial flops

Thousands of studies are registered each year, so there is always an array of disappointing results to choose from for our annual top 10 list.
Phil Taylor Mar 1, 2022 3:00am
AbbVie

AbbVie's Skyrizi aces ulcerative colitis induction study

Mar 23, 2023 10:57am
AbbVie

AbbVie's Skyrizi clears psoriasis where Cosentyx, Taltz couldn't

Mar 18, 2023 10:00am
Xtandi

Astellas, Pfizer eye new prostate cancer use for Xtandi

Mar 17, 2023 11:18am
VTAMA cream

Dermavant's Vtama cream hits goal in first eczema phase 3 study

Mar 15, 2023 11:42am
Keytruda

Keytruda catches up with Opdivo in rare lung cancer type

Mar 10, 2023 10:00am
More News

AstraZeneca touts 2 lung cancer wins as Keytruda showdown looms

Mar 9, 2023 11:26am

FDA casts doubt on Roche's Polivy filing in first-line lymphoma

Mar 7, 2023 3:06pm

Is a tumor-agnostic approval next for AZ and Daiichi's Enhertu?

Mar 6, 2023 11:17am

Roche, Exelixis' Tecentirq-Cabometyx fails a 3rd time

Mar 3, 2023 11:44am
See more stories
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy